NL1011875A1 - Nieuwe verbinding. - Google Patents

Nieuwe verbinding.

Info

Publication number
NL1011875A1
NL1011875A1 NL1011875A NL1011875A NL1011875A1 NL 1011875 A1 NL1011875 A1 NL 1011875A1 NL 1011875 A NL1011875 A NL 1011875A NL 1011875 A NL1011875 A NL 1011875A NL 1011875 A1 NL1011875 A1 NL 1011875A1
Authority
NL
Netherlands
Prior art keywords
new connection
new
connection
Prior art date
Application number
NL1011875A
Other languages
English (en)
Other versions
NL1011875C2 (nl
Inventor
Andrew Simon Craig
Alan David Jones
Deirdre O'keeffe
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1011875(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9814316.7A external-priority patent/GB9814316D0/en
Priority claimed from GBGB9821732.6A external-priority patent/GB9821732D0/en
Priority claimed from GBGB9902935.7A external-priority patent/GB9902935D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NL1011875A1 publication Critical patent/NL1011875A1/nl
Application granted granted Critical
Publication of NL1011875C2 publication Critical patent/NL1011875C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
NL1011875A 1998-07-02 1999-04-23 Nieuwe verbinding. NL1011875C2 (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9814316 1998-07-02
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
GBGB9821732.6A GB9821732D0 (en) 1998-10-06 1998-10-06 Novel compound
GB9821732 1998-10-06
GBGB9902935.7A GB9902935D0 (en) 1999-02-10 1999-02-10 Novel compound
GB9902935 1999-02-10

Publications (2)

Publication Number Publication Date
NL1011875A1 true NL1011875A1 (nl) 2000-01-07
NL1011875C2 NL1011875C2 (nl) 2000-03-24

Family

ID=27269380

Family Applications (4)

Application Number Title Priority Date Filing Date
NL1011874A NL1011874C1 (nl) 1998-07-02 1999-04-23 Nieuwe verbinding.
NL1011875A NL1011875C2 (nl) 1998-07-02 1999-04-23 Nieuwe verbinding.
NL1012271A NL1012271C2 (nl) 1998-07-02 1999-06-08 Nieuwe verbinding.
NL1012272A NL1012272C1 (nl) 1998-07-02 1999-06-08 Nieuwe verbinding.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL1011874A NL1011874C1 (nl) 1998-07-02 1999-04-23 Nieuwe verbinding.

Family Applications After (2)

Application Number Title Priority Date Filing Date
NL1012271A NL1012271C2 (nl) 1998-07-02 1999-06-08 Nieuwe verbinding.
NL1012272A NL1012272C1 (nl) 1998-07-02 1999-06-08 Nieuwe verbinding.

Country Status (35)

Country Link
US (4) US6063927A (nl)
EP (5) EP0970955B1 (nl)
JP (1) JP2002519422A (nl)
KR (1) KR20010053336A (nl)
CN (1) CN1127502C (nl)
AR (2) AR011759A1 (nl)
AT (4) ATE195121T1 (nl)
AU (4) AU732211C (nl)
BE (3) BE1011664A6 (nl)
BR (1) BR9911682A (nl)
CA (1) CA2269999A1 (nl)
CH (1) CH689805A8 (nl)
DE (5) DE69900007T2 (nl)
DK (7) DK199900176U3 (nl)
ES (4) ES2149044T3 (nl)
FI (2) FI4209U1 (nl)
FR (2) FR2780728B1 (nl)
GB (5) GB2377637A (nl)
GR (3) GR990100140A (nl)
HK (1) HK1037877A1 (nl)
HU (1) HUP0102334A3 (nl)
IE (5) IE990344A1 (nl)
IL (1) IL140628A (nl)
IT (1) IT1312540B1 (nl)
LU (1) LU90388B1 (nl)
NL (4) NL1011874C1 (nl)
NO (1) NO319030B1 (nl)
NZ (1) NZ509180A (nl)
PL (1) PL345214A1 (nl)
PT (4) PT1089996E (nl)
SE (1) SE9901462A0 (nl)
SI (3) SI1089996T1 (nl)
SK (1) SK20262000A3 (nl)
TR (1) TR200100054T2 (nl)
WO (1) WO2000001694A1 (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
AU734548B2 (en) * 1997-02-27 2001-06-14 Ajinomoto Co., Inc. Apparatus and method for crystallization
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040028582A1 (en) * 1999-03-10 2004-02-12 Smithkline Beecham Corporation Crystallization process for producing fine crystal products
USPP12225P2 (en) 1999-06-01 2001-11-27 Florfis Ag Geranium plant named ‘Fislamda’
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1412350A1 (en) * 2001-08-02 2004-04-28 Spurcourt Limited Paroxetine isethionate salt, process of preparation and use in the treatment of depression
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
EP1778183B1 (en) * 2004-08-18 2018-06-27 Synthon B.V. Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
BRPI0609749A2 (pt) 2005-04-07 2011-10-18 Chata Biosystems sistema de acondicionamento de caminho de fluxo
CA2629514A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
EP1966192B1 (en) * 2005-12-01 2012-10-17 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN101627031A (zh) * 2007-03-09 2010-01-13 诺瓦提斯公司 3-(1h-吲哚-3-基)-4-[2-(4-甲基-哌嗪-1-基)-喹唑啉-4-基]-吡咯-2,5-二酮的盐
US8119688B2 (en) * 2007-09-19 2012-02-21 Xy, Llc Differential evaporation potentiated disinfectant system
US20100249166A1 (en) 2007-09-19 2010-09-30 Xy, Inc. Differential evaporation potentiated disinfectant system
FR2926552B1 (fr) * 2008-01-23 2010-03-26 Biocodex Procede de preparation de particules de stiripentol ayant une granulometrie definie
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
US11111373B2 (en) 2018-12-05 2021-09-07 Chi Mei Corporation Polymethacrylate composition and optical device made therefrom, and display apparatus

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE99678C (nl) *
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
DE3677712D1 (de) * 1985-10-21 1991-04-04 Honda Motor Co Ltd Methode zur steuerung des spulenstroms eines magnetventils, das die saufluftmenge eines innenverbrennungsmotors steuert.
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
JPS63141967A (ja) * 1986-11-21 1988-06-14 エイ・エッチ・ロビンス・カンパニー・インコーポレーテッド 抗アレルギー薬として有用な１−アリールオキシー４−［（４−アリール）−１−ピペラジニル］−２−ブタノール
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
JP2773587B2 (ja) * 1992-11-30 1998-07-09 東レ株式会社 Ｏ，ｏ´−ジアシル酒石酸無水物の製造法
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
US5546683A (en) * 1993-09-29 1996-08-20 Clark; George J. Bucket attachment device with remote controlled retractable pins
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5668134A (en) * 1994-01-28 1997-09-16 G. D. Searle & Co. Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
CA2143070C (en) * 1994-02-22 2001-12-18 Pankaj Modi Oral controlled release liquid suspension pharmaceutical formulation
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
CA2220963A1 (en) * 1995-05-17 1996-11-21 Novo Nordisk A/S Process for preparing 4-aryl-piperidine derivatives
JP2813768B2 (ja) * 1995-05-24 1998-10-22 農林水産省家畜衛生試験場長 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
EP0858460A1 (en) * 1995-10-31 1998-08-19 Merck & Co., Inc. Process for preparing substituted azetidinones
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
GB9526645D0 (en) * 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
JP3446468B2 (ja) * 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1384711A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optical resolution of a piperidine derivative
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine
WO1999047519A1 (en) * 1998-03-16 1999-09-23 Smithkline Beecham Plc Crystalline form of paroxetine
BR9909529A (pt) * 1998-04-09 2000-12-12 Smithkline Beecham Plc Maleato de paroxetina
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat

Also Published As

Publication number Publication date
CN1127502C (zh) 2003-11-12
CH689805A5 (fr) 1999-11-30
DK199900234U1 (da) 2000-12-22
AT3185U2 (de) 1999-11-25
JP2002519422A (ja) 2002-07-02
ES2158778A1 (es) 2001-09-01
ES2158778B1 (es) 2002-03-16
BR9911682A (pt) 2001-12-26
CN1315949A (zh) 2001-10-03
EP1020464B1 (en) 2001-07-04
GB2367003A (en) 2002-03-27
FI112077B (fi) 2003-10-31
AR018197A1 (es) 2001-10-31
WO2000001694A1 (en) 2000-01-13
DE69900007D1 (de) 2000-09-07
NZ509180A (en) 2001-06-29
US6063927A (en) 2000-05-16
DK199900234U4 (da) 2000-12-22
US20020035130A1 (en) 2002-03-21
GB2339428A (en) 2000-01-26
ITMI990866A1 (it) 2000-10-23
FIU990190U0 (fi) 1999-04-23
GR3036208T3 (en) 2001-10-31
US20020193406A1 (en) 2002-12-19
AU732211B2 (en) 2001-04-12
ATE195121T1 (de) 2000-08-15
NL1012272C1 (nl) 1999-07-12
CA2269999A1 (en) 2000-01-02
EP1020464A1 (en) 2000-07-19
SE9901462A0 (sv) 2000-01-03
DE19918588A1 (de) 2000-01-27
AT3185U3 (de) 2000-01-25
DE60000003T2 (de) 2002-03-21
AR011759A1 (es) 2000-09-13
IE990344A1 (en) 2000-05-03
HUP0102334A3 (en) 2003-12-29
DE29907248U1 (de) 1999-09-09
FR2802098A1 (fr) 2001-06-15
DE60000003D1 (de) 2001-08-09
GR990100140A (el) 2000-03-31
HUP0102334A2 (hu) 2002-05-29
DE69911774D1 (de) 2003-11-06
ES2209428T3 (es) 2004-06-16
FI4209U1 (fi) 1999-11-10
GR1003350B (el) 2000-03-29
IL140628A0 (en) 2002-02-10
DE69911774T2 (de) 2004-08-05
NL1012271A1 (nl) 1999-07-12
PT1089996E (pt) 2004-02-27
IES990343A2 (en) 2000-01-02
SI1089996T1 (en) 2004-04-30
BE1012403A5 (fr) 2000-10-03
TR200100054T2 (tr) 2001-06-21
ATE202777T1 (de) 2001-07-15
GB0026487D0 (en) 2000-12-13
GR3034328T3 (en) 2000-12-29
DK0970955T3 (da) 2000-10-09
EP1020463A1 (en) 2000-07-19
DK1089996T3 (da) 2004-02-09
AU713877B3 (en) 1999-12-09
DK199900554A (da) 2000-01-03
GB2336364B (en) 2000-05-10
FR2780728B1 (fr) 2001-02-16
GB2336364A (en) 1999-10-20
AU2392899A (en) 2000-01-20
ES2149044T3 (es) 2000-10-16
PT102291A (pt) 2000-05-31
NL1011874C1 (nl) 1999-07-12
PT102291B (pt) 2002-07-31
ATE251155T1 (de) 2003-10-15
GB9920332D0 (en) 1999-11-03
FI990922A (fi) 2000-01-03
GB9909505D0 (en) 1999-06-23
IES20000894A2 (en) 2001-05-30
IT1312540B1 (it) 2002-04-22
IL140628A (en) 2004-06-20
LU90388B1 (fr) 2001-01-29
PT1020464E (pt) 2001-10-30
SI1020464T1 (en) 2001-12-31
AU713131B3 (en) 1999-11-25
DK200000390U1 (da) 2000-12-27
NO319030B1 (no) 2005-06-06
AU3619199A (en) 2000-01-24
IES20000893A2 (en) 2001-05-30
GB0119695D0 (en) 2001-10-03
GB0216752D0 (en) 2002-08-28
ES2157881T3 (es) 2001-09-01
EP0970955A1 (en) 2000-01-12
NL1011875C2 (nl) 2000-03-24
CH689805A8 (fr) 2000-02-29
HK1037877A1 (en) 2002-02-22
SE9901462D0 (sv) 1999-04-23
IE20000633A1 (en) 2001-10-17
EP1288214A1 (en) 2003-03-05
SE9901462L (nl)
FI990922A0 (fi) 1999-04-23
BE1011664A6 (fr) 1999-11-09
KR20010053336A (ko) 2001-06-25
GB2377637A (en) 2003-01-22
DE69900007T2 (de) 2001-06-07
BE1012420A6 (fr) 2000-10-03
GB2352395A (en) 2001-01-31
FR2780728A1 (fr) 2000-01-07
PL345214A1 (en) 2001-12-03
PT970955E (pt) 2000-11-30
EP1089996A1 (en) 2001-04-11
DK1020464T3 (da) 2001-09-24
AU732211C (en) 2004-05-06
GB2352395B (en) 2004-02-11
DK199900176U3 (da) 1999-08-13
EP1089996B1 (en) 2003-10-01
SK20262000A3 (sk) 2001-07-10
NO991944D0 (no) 1999-04-23
EP0970955B1 (en) 2000-08-02
NO991944L (no) 2000-01-03
SI0970955T1 (en) 2001-02-28
NL1012271C2 (nl) 1999-09-23
US20010023253A1 (en) 2001-09-20
IES81166B2 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
NL1012271A1 (nl) Nieuwe verbinding.
CU23049A3 (es) Dihidropirimidinas.
NL1012222A1 (nl) Nieuwe O-acyloxim-fotoinitiatoren.
BR9904942B1 (pt) mangueira.
FI980536A (fi) Kokoonpanolinja
IT1302016B1 (it) Fluoroelastomeri.
NL1008575A1 (nl) Nieuwe formulering.
BR9908946B1 (pt) forração.
ES1036909Y (es) Pupitre infantil.
NL1011592A1 (nl) Ondersteuningsconstructie.
ES1037395Y (es) Tendedero antilluvia.
ITDP980003A1 (it) Nessuna.
ES1039730Y (es) Rodapie.
ES1040343Y (es) Carrito portafregona.
ES1040589Y (es) Expositor-dispensador.
ES1042117Y (es) Mesa-sombrilla.
ES1040731Y (es) Gafa.
ES1040633Y (es) Escalifono.
ES1039413Y (es) Nueva ficha-deportista.
ITBO980260A1 (it) Riavvolgicarta.
ITNA980067A1 (it) Bloccatappo.
ITDP980002A1 (it) Vedi descrizione.
ES1040336Y (es) Lingote mejorado.
ES1039687Y (es) Linterna.
IT244808Y1 (it) Verricello .

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 19991220

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20091101